Clinical Trials Logo

Fissure in Ano clinical trials

View clinical trials related to Fissure in Ano.

Filter by:

NCT ID: NCT04793347 Enrolling by invitation - Clinical trials for Chronic Anal Fissure

Effect of Shock Waves Therapy on Chronic Anal Fissure

Start date: March 10, 2021
Phase: N/A
Study type: Interventional

the study conducted to assess if there is an effect of Extracorporeal Shock Wave Treatment on anal fissure

NCT ID: NCT04714684 Not yet recruiting - Fissure in Ano Clinical Trials

The Role of Fitostimoline Proctogel in Symptoms Relief and Healing in Patients Affected by Anal Fissure

Start date: February 10, 2021
Phase: N/A
Study type: Interventional

Evaluate the effectiveness of fitostimoline proctogel in the anal fissure healing and in the need for invasive interventions (primary endpoints) and in the healing of the fissure (secondary endpoint) using Fitostimoline in addition to or without other topical devices available on the market. Three groups will be established: one for the exclusive use of fitostimoline, the second for the use of fitostimoline in addition to one of the other topical devices already on the market and the third group only for the use of other topical therapies.

NCT ID: NCT04604483 Not yet recruiting - Fissure in Ano Clinical Trials

Percutaneous Tibial Nerve Stimulation (PTNS) for the Treatment of Chronic Anal Fissure

Start date: October 1, 2024
Phase: N/A
Study type: Interventional

Chronic anal fissure rarely heals spontaneously. About 50% heal on administration om topical muscle relaxants (e.g. diltiazem) and/or injection of Botulinum toxin, but for the remainder of patients surgery (with lateral internal sphincterotomy or fissurectomy) with subsequent risks of anal incontinence has been the golden standard. Treatment with PTNS (percutaneous tibial nerve stimulation) has been showed to produce healing of chronic anal fissures not responding to topical treatment, thus avoiding the risk for debilitating anal incontinence.

NCT ID: NCT04428697 Active, not recruiting - Anal Fissure Clinical Trials

Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique

Start date: May 1, 2013
Phase: N/A
Study type: Interventional

BACKGROUND: Currently, the lateral internal sphincterotomy is the treatment of choice for a chronic anal fissure. However, the length of the internal sphincter incision varies, due to lack of standardization. Insufficient length increases the risk of recurrence. OBJECTIVE: To compare a new ultra-modified internal sphincterotomy technique to the closed lateral sphincterotomy for treating chronic anal fissures, based on internal anal sphincter function and postoperative complications. DESIGN: Prospective, randomized, controlled trial (block randomization method) SETTING: Pamukkale University hospital in Denizli-Turkey PARTICIPANTS: 200 patients with chronic anal fissures INTERVENTION: Patients were randomly assigned to receive either Sungurtekin technique (n = 100; ultra-modified group), or the closed lateral internal sphincterotomy (n = 100; closed-lateral group). Follow-up was 2 years. MAIN OUTCOME MEASURES: The primary outcome was chronic anal fissure healing. The secondary outcomes were complications, visual analog scale pain scores, sphincter pressures, and incontinence scores.

NCT ID: NCT04320498 Completed - PRP Clinical Trials

Short Term Results of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure

Start date: January 1, 2019
Phase: Phase 4
Study type: Interventional

Autologous PRP currently has many uses in surgical and medical therapy. Compared with other regenerative therapies, PRP is easy-to-prepare, low-cost, and does not require complex equipment. The use of autologous PRP avoids immunological side effects. Data is lacking on the use of PRP in the treatment of anal fissure. This study evaluated PRP as an alternative medical treatment for chronic anal fissures.

NCT ID: NCT04173130 Completed - Anal Fissure Clinical Trials

Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin

Start date: November 11, 2019
Phase: N/A
Study type: Interventional

Monocentric feasibility study for a new device for the treatment of anal fissure with botulinum toxin.

NCT ID: NCT04166175 Completed - Clinical trials for Chronic Anal Fissure

High Dose Multiple Site Injection of Botox Versus Lateral Sphincterotomy in Chronic Analfissure

professor
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

comparison between the effect of lateral sphincterotomy against high dose botox injection in chronic anal fissure the outcome was healing time, recurrence continence relapse pain pruritus

NCT ID: NCT04153032 Recruiting - Anal Fissure Clinical Trials

Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure

MEBO
Start date: December 1, 2019
Phase: Phase 2
Study type: Interventional

No study to date has compared topical DTZ to MEBO ointment in the treatment of anal fissure. Therefore, the present study aims to compare the efficacy and safety of DTZ to MEBO in the treatment of acute anal fissure. The investigators propose to conduct a comparative randomized clinical study. In this study, the investigators will compare patients with acute anal fissure receiving MEBO ointment vs Topical DTZ ointment vs a combination of MEBO and DTZ ointment. Hypothesis: MEBO in combination with DTZ is more effective than DTZ or MEBO alone in the treatment of acute anal fissure.

NCT ID: NCT03920449 Recruiting - Clinical trials for Chronic Anal Fissure

Postero-lateral Internal Sphincterotomy vs Botulinum Toxin Injection in the Treatment of Chronic Anal Fissure

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

We hypothesized that optimization of the dose of the Botulinum toxin injection (BT) and standardization of the technique of lateral internal sphincterotomy to posterolateral internal sphincterotomy (PIAS) could, in turn, report a conclusive result which helps to provide better care to patients with chronic anal fissure. So, we will conduct this trial as a prospective randomized, controlled, intervention, open-label trial with two parallel groups, and a primary endpoint of fissure healing during 6 months after the initial intervention, with the randomization, will be performed by an online software with a 1:1 allocation. Eligible patients will be randomized in equal proportions between BT injection and PIAS.

NCT ID: NCT03872765 Completed - Clinical trials for Chronic Anal Fissure

Outcomes of the Use of CO2 (Carbon Dioxide) Laser in the Treatment of Chronic Anal Fissure

Start date: January 14, 2012
Phase: N/A
Study type: Interventional

Outcomes of using CO2 (Carbon Dioxide) laser in the management of chronic anal fissure as an alternative to conventional methods